anakinra (Kineret)

From Aaushi
Jump to navigation Jump to search

Indications

* rarely used for rheumatoid arthritis since other biologic DMARDs superior[4]

Contraindications

Pregnancy category: B

Dosage

Monitor

Adverse effects

Laboratory

Mechanism of action

Management

Notes

Manufacturer: Amgen

More general terms

Additional terms

References

  1. Prescriber's Letter 9(2):S1 2002
  2. Prescriber's Letter 9(3):13 2002
  3. Jump up to: 3.0 3.1 Journal Watch 22(9):70, 2002 Dayer J-M & Bresniban R, Targeting interleukin-1 in the treatment of rheumatoid arthritis. Arthritis Rheum 46:574, 2002 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11920390
  4. Jump up to: 4.0 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 Medical Knowledge Self Assessment Program (MKSAP) 16, 17, 18, 19. American College of Physicians, Philadelphia 2012, 2015, 2018, 2022.
  5. Jump up to: 5.0 5.1 Thueringer JT, Doll NK, Gertner E. Anakinra for the treatment of acute severe gout in critically ill patients. Semin Arthritis Rheum. 2015 Aug;45(1):81-5. Epub 2015 Feb 20. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25795473
  6. Jump up to: 6.0 6.1 Liew JW, Gardner GC. Use of anakinra in hospitalized patients with crystal-associated arthritis. J Rheumatol 2019 Oct; 46:1345 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/30647192 <Internet> http://www.jrheum.org/content/46/10/1345